##plugins.themes.academic_pro.article.main##
Abstract
The article is devoted to one of the most common rheumatic diseases — juvenile arthritis (JA). The main issues of epidemiology, classification, pathogenesis are considered, in more detail — the clinical picture of different variants of the course of JA, diagnostics and differential diagnosis. The treatment section describes the drugs used in JA, and presents an algorithm for differentiated treatment of the disease. Approaches to biological therapy, conditions for prescribing and management of patients receiving genetically engineered biological drugs are described separately.
Keywords
children
etanercept
juvenile arthritis
adalimumab
##plugins.themes.academic_pro.article.details##

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
Akhmedov B.U. (2025). Clinical Pharmacological Approach To The Drug Treatment Of Arthritis, Arthralgia And Back Pain Syndromes. Texas Journal of Medical Science, 42, 60–62. Retrieved from https://zienjournals.com/index.php/tjms/article/view/6021
References
- Bijlsma JWJ, Berenbaum F, Lafeber FPJG. Osteoarthritis: an update with relevance for clinical
- practice. Lancet. 2011;377(9783):2115-2126.
- Firestein GS, McInnes IB. Immunopathogenesis of rheumatoid arthritis. Immunity. 2017;46(2):183-
- McAlindon TE, Bannuru RR, Sullivan MC, et al. OARSI guidelines for the non-surgical
- management of knee osteoarthritis. Osteoarthritis Cartilage. 2014;22(3):363-388.
- Hochberg MC, Altman RD, April KT, et al. American College of Rheumatology 2012
- recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of
- the hand, hip, and knee. Arthritis Care Res (Hoboken). 2012;64(4):465-474.
- Kolasinski SL, Neogi T, Hochberg MC, et al. 2019 American College of Rheumatology/Arthritis
- Foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis
- Rheumatol. 2020;72(2):220-233.
- Cohen SP, Vase L, Hooten WM. Chronic pain: an update on burden, best practices, and new
- advances. Lancet. 2021;397(10289):2082-2097